Home > Insider Trading > Filing (0001437749-13-009182)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1492646	Frances Gail Mcintyre	C/O Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150 Morrisville NC 27560	Senior Vice President-Research	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-07-19	20,000	$9.11	37,868	No	4	M	Direct
Common Stock	Disposition	2013-07-19	9,419	$40.00	28,449	No	4	F	Direct
Common Stock	Disposition	2013-07-19	10,581	$40.00	17,868	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (to buy)	Acquisiton	2013-07-19	20,000	$0.00	20,000	$9.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
55,691		2020-06-17	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (to buy)	$15.00	2021-05-09	26,000	26,000	Direct
Common Stock	Stock Options (to buy)	$13.16	2021-10-03	37,944	37,944	Direct
Common Stock	Stock Options (to buy)	$17.80	2022-02-24	10,368	10,368	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-05-09	26,000	26,000	Direct
2021-10-03	37,944	37,944	Direct
2022-02-24	10,368	10,368	Direct

Footnotes

This sale was pursuant to a Rule 10b5-1 Sales Plan, which is intended to comply with Rule 10b5-1.
The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 2/24/2012 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.